Integrated PET MRI Scanners Hold Significant Revenue Share in the Market
In oncology, staging forms the basis for prognostic consideration and directly influences patient care by determining the therapeutic approach. After the successful introduction of PET/CT, the search for appropriate PET/MRI instrumentation as another bimodal imaging tool was intensified.
With first prototypes of a 3T PET MRI scanner for brain imaging equipped with APDs, Siemens brought out a full-body integrated PET/MRI scanner at 3T using the same technology in 2010. These integrated PET MRI scanners are expected to remain a prominent component of the PET MRI market as these products are able to acquire images simultaneously for diagnostic purpose, thus being preferred for clinical purposes.
On the other hand, the adoption of PET inserts is expected to grow at a significant rate due to their cost effectiveness for pre-clinical research and increasing acceptance by biopharmaceutical companies, which carry out extensive preclinical studies in animal models.
Synchronization of Screening Techniques to Aid Patient Comfort
Manufacturers of PET MRI scanners are shifting to technologies and product specifications that tend to consume lesser efforts for production and offer non-invasive diagnosis, reliability of the screening results, as well as testing with lesser tracer doses and low ionizing radiation exposure as experienced in PET/CT scanners or invasive staging procedures like biopsy. Workflow management which was considered as an impeding factor in functioning of conventional modalities like PET/CT or sequential PET/MRI scanners due to necessity of moving patients from one device to another is overcome.
Technological advancements in tracers have led to the requirement of lesser quantity of tracer doses and quicker results are expected to be ensure convenience for people already suffering from various kinds of dementia. Features like these are anticipated to provide added incentives for healthcare professionals to opt for PET MRI-based imaging.
R&D Funds for Research Institutes to Increase Demand for PET MRI Scanners
The increasing burden of incurable and rare diseases has resulted in an unmet need for multi-modal imaging techniques, which aid in understanding the mechanism of disease progression. The demand from researchers for newly available modality is increasing the installation of PET MRI in research institutes.
For instance, European Institute for Biomedical imaging (EIBIR) coordinated along with 10 partners, on a funding of €5,861,957 for a project named Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer (HYPMED). The HYPMED project is a four-year project aimed at developing a hybrid system of two medical imaging modalities (MRI and PET) for improved diagnosis of breast cancer and personalized therapy control.
Need Gap Exists for Large Number of Patients as Selected Diagnostic Facilities offer PET MRI Currently
According to WHO’s GLOBOCAN 2018 database, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide develop cancer during their lifetime. The patients with rare form of ulcers, lesions and tumors are required to undergo PET/MRI screening to confirm occurrence and recurrence of disease. Rising prevalence of congenital cardiac disorders, oncological onset, traumatic injuries post-surgery, and inflammation which cannot be diagnosed with any other modality have led to the installation of PET MRI scanners in hospitals for clinical purposes. On the other hand, limited number of PET MRI scanners prove to be an opportunity for manufacturers to enter the highly consolidated PET MRI market.
Edge over Traditional Configuration and Modalities
Functional attributes of PET MRI position them above other conventional diagnostic devices available in the market, such as X-ray, ultrasound, CT scan, standalone PET or MRI, PET-CT in terms of ease and convenience. Hence, it is expected that the former will continue to gain preference despite the significantly large utilization of conventional imaging methods. PET MRI are used in the diagnosis of numerous oncological conditions including tumors of brain, head, neck, chest, abdomen, pelvis, bone, soft-tissues, and malignancies like melanoma and lymphoma.
Innovative Technological Upgradations with Increasing Frequency
The introduction of new hardware designs, technologies, and software has been directing the focus of manufacturers towards development of devices with advanced technical characteristics such as SUVmax, axial/transaxial field of view, avalanche photodiodes, silicon photomultipliers, and PET inserts that can be accommodated within a MRI gantry to enable concurrent image acquisitions.
Unique Functionality of PET MRI to Lend Imperatives to Oncologists
From diagnosis to prognosis, PET MRI scan results decide the treatment to be suggested by a healthcare provider. Moreover, TNM staging of cancer by nuclear medicine expert or radiologist can be fruitful when malignancy makes it cumbersome to detect tumors, which spread throughout the body. Localization of lesions, tumor characterization, post-therapy scar, and radiotracer efficiency are some of the topics of clinical studies within oncology that lend imperatives to oncologists.
Highly Capital Intensive Product Development Resulting in Top-Heavy Competition Landscape
GE Healthcare, Siemens AG, and Koninklijke Philips are the three top players operating in the PET MRI market. Top players in the market are expected to hold approximately 85% of the revenue share in the overall market during the forecasted period. Other players present in the market are focused on collaboration with top players to supply components. Another approach followed by players is research collaboration with leading research institutes. For example, Cubresa Inc., the PET insert company, signed an agreement with Department of Medical Imaging and the University of Arizona BIO5™ Institute in order to fully exploit a unique MRI method and the synthesis of contrast agents that relies on patented technology from Pagel’s lab to measure a tumor’s acidity.
Increasing acceptance of PET MRI scanners, especially in developed countries like the U.S, Japan, and Germany is spurring the growth of the global PET MRI market. Furthermore, the higher adoption of PET Inserts for pre-clinical applications is more likely to support the growth of the PET MRI market over the forecast period. The PET MRI market is expected to have a robust growth in the forecast period owing to new screening techniques, equipment design, innovative product launches through international conferences and collaborative associations.
PET MRI Market - Scope of the Report
Persistence Market Research (PMR) recently published a market study on the global market for PET MRI. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the PET MRI market structure. The market study presents exclusive information about how the PET MRI market will grow during the forecast period of 2019 - 2029.
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the PET MRI market during the forecast period.
The study is relevant for stakeholders in the PET MRI market, including PET MRI manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the PET MRI market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR’s study.
The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the PET MRI market. Furthermore, small businesses and new entrants in the PET MRI market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.
Key Segments of the PET MRI Market
PMR’s study on the PET MRI market offers information divided into six important segments - Product Type, PET Imaging Technology, Image Acquisition, Applications, End User and by Region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
PET Imaging Technology
Key Questions Answered in PMR’s PET MRI Market Report
PET MRI Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the PET MRI market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to analysts during the production of the PET MRI market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the PET MRI market, and makes PMR’s projection on the growth prospects of the PET MRI market more accurate and reliable.